First-Generation EGFR-TKI Plus Chemotherapy Versus EGFR-TKI Alone as First-Line Treatment in Advanced NSCLC With EGFR Activating Mutation: A Systematic Review and Meta-Analysis of...

por Wu, Qiang, Luo, Wuxia, Li, Wen, Wang, Ting, Huang, Lin, Xu, Feng
Publicado 2021

Prognostic Value of Ki-67 in Patients With Resected Triple-Negative Breast Cancer: A Meta-Analysis

por Wu, Qiang, Ma, Guangzhi, Deng, Yunfu, Luo, Wuxia, Zhao, Yaqin, Li, Wen, Zhou, Qinghua
Publicado 2019